The results of the multicenter PIONEER trials were published in the New England Journal of Medicine. Among the co-authors of the paper was Dr. Evangelos J. Giamarellos-Bourboulis, Associate Professor of Internal Medicine at the Medical School of the National and Kapodistrian University of Athens. The paper analyzes the efficacy of adalimumab in hidradenitis suppurativa. The OutPatients Department of Immunology of Infections at ATTIKON University hospital that is under the supervision of Dr. Giamarellos was the top recruiter global site. The value of this publication is further outscored by the granted registration of adalimumab for hidradenitis suppurativa by both the Food and Drug Administration of USA and by the European Medicines Agency based on these results. The publication is available at the following link.
